Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use
Deciphera Pharmaceuticals recently took a serious hit to its billion-dollar hopeful cancer drug Qinlock. As the company undertakes a round of layoffs to deal with the...
Continue Reading →
